Cargando…
The Extraglycemic Effect of SGLT-2is on Mineral and Bone Metabolism and Bone Fracture
Type 2 diabetes mellitus (T2DM) is a risk factor for osteoporosis. The effects of T2DM and anti-diabetic agents on bone and mineral metabolism have been observed. Sodium–glucose co-transporter 2 inhibitors (SGLT-2is) promote urinary glucose excretion, reduce blood glucose level, and improve the card...
Autores principales: | Dong, Bingzi, Lv, Ruolin, Wang, Jun, Che, Lin, Wang, Zhongchao, Huai, Zhouyang, Wang, Yangang, Xu, Lili |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9302585/ https://www.ncbi.nlm.nih.gov/pubmed/35872985 http://dx.doi.org/10.3389/fendo.2022.918350 |
Ejemplares similares
-
Cardiovascular-renal protective effect and molecular mechanism of finerenone in type 2 diabetic mellitus
por: Lv, Ruolin, et al.
Publicado: (2023) -
Extraglycemic Effects of SGLT2 Inhibitors: A Review of the Evidence
por: Bonora, Benedetta Maria, et al.
Publicado: (2020) -
The Emerging Role of Bone-Derived Hormones in Diabetes Mellitus and Diabetic Kidney Disease
por: Li, Yixuan, et al.
Publicado: (2022) -
Hyperuricemia and the Risk of Heart Failure: Pathophysiology and Therapeutic Implications
por: Si, Ke, et al.
Publicado: (2021) -
Associations of LRP5 Gene With Bone Mineral Density, Bone Turnover Markers, and Fractures in the Elderly With Osteoporosis
por: Wang, Qi-Fei, et al.
Publicado: (2020)